Autologous stem cell transplantation for autoimmune diseases: Issues in protocol development

Journal of Rheumatology

Volumn 24, Issue SUPPL. 48, 1997, Pages 79-84

  McSweeney, Peter A ^a,b   Nash, Richard A ^a,b,c   Storb, Rainer ^a,b,c   Furst, Daniel E ^a,c,d   Gauthier, Joyce ^a,c   Sullivan, Keith M ^a,b,c  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d BENAROYA RESEARCH INSTITUTE   (United States)

Author keywords

Antithymocyte globulin; Autoimmune disease; Growth factors; Stem cells; Total body irradiation

Indexed keywords

ANTIBODY; BUSULFAN; CARMUSTINE; CD34 ANTIGEN; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEMOPOIETIC GROWTH FACTOR; MELPHALAN; THIOTEPA; THYMOCYTE ANTIBODY;

AUTOIMMUNITY; AUTOTRANSPLANTATION; CONFERENCE PAPER; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; NONHUMAN; PATIENT SELECTION; PRIORITY JOURNAL; PURIFICATION; STEM CELL TRANSPLANTATION; THERAPY; WHOLE BODY RADIATION; ANIMAL; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL PROTOCOL; DISEASE FREE SURVIVAL; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; METHODOLOGY; MORTALITY; MOUSE; SURVIVAL RATE; TREATMENT OUTCOME;

ANIMALS; AUTOIMMUNE DISEASES; CLINICAL PROTOCOLS; DISEASE-FREE SURVIVAL; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MICE; SURVIVAL RATE; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 0030989980     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Marmont AM: Autoimmunity and allogeneic bone marrow transplantation. Bone Marrow Transplant 1992;9:1-3.
2. Marmont AM: Immune ablation followed by allogeneic or autologous bone marrow transplantation: A new treatment for severe autoimmune diseases. Stem Cells 1994;12:125-35.
3. van Bekkum DW: BMT in experimental autoimmune diseases. Bone Marrow Transplant 1993;11:183-7.
4. Burt RK, Burns W, Hess A: Bone marrow transplantation for multiple sclerosis. Bone Marrow Transplant 1995;19:1-6.
5. Yurovsky VV, Sutton PA, Schulze DH, et al: Expansion of selected V delta+ gamma delta T cells in systemic sclerosis patients. J Immunol 1994;153:881-91.
6. Nelson JL, Torrez R, Louie FM, Choe OS, Storb R, Sullivan KM: Preexisting autoimmune disease in patients with longterm survival after allogeneic bone marrow transplantation. J Rheumatol 1997;(suppl 48)24:23-9.
7. Roubenoff R, Jones RJ, Karp JE, Stevens MB: Remission of rheumatoid arthritis with the successful treatment of acute. myelogenous leukemia with cytosine arabinoside, daunorubicin, and m-AMSA. Arthritis Rheum 1987;30:1187-90.
8. Comer M, Harvey AR: Remission of scleroderma during chemotherapy for lymphoma. Ann Rheum Dis 1992;51:998-1000.
9. Good RA, Ikehara S: Preclinical investigations that subserve efforts to employ bone marrow transplantation for rheumatoid or autoimmune diseases. J Rheumatol 1997;(suppl 48)24:5-12.
10. Pearson CM, Wood FD: Passive transfer of adjuvant arthritis by lymph node or spleen cells. J Exp Med 1964;120:547-60.
11. Walker MA, Harley RA, DeLustro FA, Leroy EC: Adoptive transfer of tsk skin fibrosis to +/+ recipients by tsk bone marrow and spleen cells. Proc Soc Exp Biol Med 1989;192:196-200.
12. Morton JI, Siegel BV: Transplantation of autoimmune potential. I. Development of antinuclear antibodies in H-2 histocompatible recipients of bone marrow from New Zealand Black mice. Proc Natl Acad Sci USA 1974;71:2162-5.
13. Ikehara S, Kawamura M, Takao F, et al: Organ-specific and systemic autoimmune diseases originate from defects in hematopoietic stem cells. Proc Natl Acad Sci USA 1990;87:8341-4.
14. Knaan-Shanzer S, Houben P, Kinwel-Bohre EP, van Bekkum DW: Remission induction of adjuvant arthritis in rats by total body irradiation and autologous bone marrow transplantation. Bone Marrow Transplant 1991;8:333-8.
15. Karussis DM, Slavin S, Lehmann D, et al: Prevention of experimental autoimmune encephalomyelitis and induction of tolerance with acute immunosuppression followed by syngeneic bone marrow transplantation. J Immunol 1992;148:1693-8.
16. van Gelder M, Kinwel-Bohre EP, van Bekkum DW: Treatment of experimental allergic encephalomyelitis in rats with total body irradiation and syngeneic BMT. Bone Marrow Transplant 1993;11:233-41.
17. Knaan-Shanzer S, Houben P, Kinwel-Bohre EP, van Bekkum DW: Remission induction of adjuvant arthritis in rats by total body irradiation and autologous bone marrow transplantation. Bone Marrow Transplant 1991;8:333-8.
18. Storb R: Hematopoietic stem cell transplantation in nonmalignant diseases. J Rheumatol 1997;(suppl 48)24:30-5.
19. Brooks P: Hematopoietic stem cell transplantation for autoimmune diseases. J Rheumatol 1997;(suppl 48)24:19-22.
20. Clift RA, Buckner CD, Thomas ED, et al: Marrow transplantation for chronic myeloid leukemia: A randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide. Blood 1994;84:2036-43.
21. Storb R, Anasetti C, Appelbaum F, et al: Marrow transplantation for severe aplastic anemia and thalassemia major. Semin Hematol 1991:28:235-9.
22. Storb R, Etzioni R, Anasetti C, et al: Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia. Blood 1994;84:941-9.
23. Bulpitt KJ, Clements PJ, Lachenbruch PA, et al: Early undifferentiated connective tissue disease. III. Outcome and prognostic indicators in early scleroderma (systemic sclerosis). Ann Intern Med 1993;118:602-9.
24. Furst DE, Clements PJ, Hillis S, et al: Immunosuppression with chlorambucil, versus placebo, for scleroderma. Results of a three-year, parallel, randomized, double-blind study. Arthritis Rheum 1989;32:584-93.
25. Bensinger W, Singer J, Appelbaum F, et al: Autologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant granulocyte stimulating factor. Blood 1993;81:3158-63.
26. Bensinger W, Appelbaum F, Rowley S, et al: Factors that influence collection and engraftment of autologous peripheral-blood stem cells. J Clin Oncol 1995;13:2547-55.
27. Bensinger WI, Weaver CH, Appelbaum FR, et al: Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 1995;85:1655-8.
28. Farhey YD, Herman JH: Vasculitis complicating granulocyte colony stimulating factor treatment of leukopenia and infection in Felty's syndrome. J Rheumatol 1995;22:1179-82.
29. Johnson ML, Grimwood RE: Leukocyte colony-stimulating factors. A review of associated neutrophilic dermatoses and vasculitides. Arch Dermatol 1994;130:77-81.
30. Shpall EJ, Jones RB, Bearman SI, et al: Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: Influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment. J Clin Oncol 1994;12:28-36.
31. Civin CI, Strauss LC, Brovall C, Fackler MJ, Schwartz JF, Shaper JH: Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells. J Immunol 1984;133:157-65.
32. Link H, Arseniev L, Bahre O, et al: Combined transplantation of allogeneic bone marrow and CD34+ blood cells. Blood 1995;86:2500-8.
33. Dreger P, Viehmann K, Steinmann J, et al: G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: Comparison of T cell depletion strategies using different CD34+ selection systems or CAMPATH-1. Exp Hematol 1995;23:147-54.
34. Witherspoon RP, Fisher LD, Schoch G, et al: Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia. N Engl J Med 1989;321:784-9.
35. Nash RA, McSweeney P, Storb R, et al: Development of a protocol for allogeneic marrow transplantation for severe systemic sclerosis. Paradigm for autoimmune disease. J Rheumatol 1997; (suppl 48)24:72-8.
36. Stone RM, Neuberg D, Soiffer R, et al: Myelodysplastic syndrome as a late complication following autologous bone marrow transplantation for non-Hodgkin's lymphoma. J Clin Oncol 1994;12:2535-42.
37. Deeg HJ, Witherspoon RP: Risk factors for the development of secondary malignancies after marrow transplantation. Hematol Oncol Clin North Am 1993;7:417-29.
38. Sullivan KM: Longterm followup and quality of life after hematopoietic stem cell transplantation. J Rheumatol 1997; (suppl 48)24:46-52.
39. 131I-labeled anti-CD45 antibody, combined with cyclophosphamide and total body irradiation. Blood 1995;85:1122-31.
40. 131I-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas. Lancet 1995;346:336-40.
41. Euler HH, Marmont AM, Bacigalupo A, et al: Early recurrence or persistence of autoimmune diseases after unmanipulated autologous stem cell transplantation. Blood 1996;88:3621-5.